ArticleOpen forum infectious diseases2025
Evaluating Connections Between Polysubstance Use, Social Drivers of Health, and Mental Health Symptoms in People With HIV.
Article in Open forum infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Multiple substance use by HIV status among United States adults, 2021-2024.Addictive behaviors reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Background: We sought to understand how no, single, and polysubstance use correlate with social drivers of health (SDOH) and mental health symptoms in persons with HIV (PWH). Methods: Cross-sectional analysis of PWH who use and do not use illicit substances and marijuana. Substance use was defined by self-report and toxicology (urine and hair). Surveys evaluated SDOH and mental health domains. Linear and logistic regression were used to assess the associations of polysubstance and single substance use with SDOH domains at risk and presence of mental health symptom domains compared to controls (no substance use). Results: A total of 171 participants were enrolled (67 polysubstance, 68 single substance, and 36 controls): 75% were male, 61% were Black, and 13% were of Hispanic ethnicity. Substance using groups were younger, had more transgender women, and higher proportion with income ≤$20 000/year. Ninety-one percent had HIV-1 RNA ≤200 copies/mL. Participants in the polysubstance group reported the most SDOH domains at risk. With adjustment, odds of transportation needs and food insecurity were 2 to 5 times higher for the substance using groups than controls. Odds of mental health symptom domains (depression, mania, anxiety, and posttraumatic stress disorder) were significantly higher in substance using groups than controls. Conclusions: Substance use is strongly associated with SDOH domains at risk and mental health symptom domains in PWH. Polysubstance use appears to be an important correlate for SDOH domains at risk and this suggests more attention in both future research and clinical care is necessary to determine interventions that will improve SDOH and health-related outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.